½ÃÀ庸°í¼­
»óǰÄÚµå
1465071

¼¼°è Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå : Á¦Ç°º°, ¿¬·ÉÃþº°, Áúȯ À¯Çüº°, ½ºÅ©¸®´× ¹æ¹ýº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2024³â-2030³â)

Mental Health Screening Market by Product, Age Group, Disease Type, Screening Method, End-User - Global Forecast 2024-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå ±Ô¸ð´Â 2023³â 18¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â 20¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.11%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. 2030³â 32¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¤½Å°Ç°­ ½ºÅ©¸®´×Àº Á¤½Å °Ç°­ Àå¾ÖÀÇ ¹ßº´ À§ÇèÀÌÀÖ´Â °³ÀÎÀ» È®ÀÎÇϰí Á¶±â °³ÀÔ°ú Áö¿øÀ» ÃËÁøÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. Á¤½Å°Ç°­¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í Á¤½Å°Ç°­ ¹®Á¦¸¦ µÑ·¯½Ñ Æí°ßÀÇ °¨¼Ò°¡ ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖÀ¸¸ç, °³ÀÎÀÌ Áö¿ø°ú Áö¿øÀ» ¿ä±¸Çϵµ·Ï Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ½ºÅ©¸®´×, ¿ø°Ý Á¤½Å ÀÇ·á, ¸ð¹ÙÀÏ Çコ ¾ÛÀ» °¡´ÉÇÏ°Ô ÇÏ´Â µðÁöÅÐ Çコ ±â¼úÀÇ Çõ½ÅÀÌ ½ÃÀåÀÇ ¹Ø´ÜÀ» ³ÐÇô °³Àο¡°Ô Á¢±ÙÇϱ⠽±°í Æí¸®ÇÑ ¼±ÅÃÀ» Á¦°øÇÕ´Ï´Ù. Á¤½Å °Ç°­ ¼­ºñ½º¸¦ ±âº» °Ç°­ °ü¸®¿¡ ÅëÇÕÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÚ±Ý Áö¿øÀº Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¹Î°¨ÇÑ Á¤½Å °Ç°­ Á¤º¸ÀÇ Ãë±Þ°ú °ü·ÃµÈ µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎ Á¤º¸ º¸È£¿¡ ´ëÇÑ ¼öºñ Àǹ«Àû ¿ì·Á°¡ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ºÅ©¸®´× µµ±¸°¡ ¹®È­ÀûÀ¸·Î ¹Î°¨ÇÏ°í ÆíÇâÀÌ ¾ø´Â °ÍÀ» º¸ÀåÇÏ´Â °ÍÀº ¿©ÀüÈ÷ ¾î·Á¿ï ¼ö ÀÖÀ¸¸ç, ´Ù¾çÇÑ Áý´ÜÀÇ Á¤È®¼º°ú ¼ö¿ë¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤½Å°Ç°­ ½ºÅ©¸®´×¿¡¼­ °³ÀÎÈ­ ¹× ¿¹Ãø ºÐ¼®À» À§ÇÑ AIÀÇ È°¿ëÀº ½ÃÀå ¹ßÀüÀÇ Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Çб³¿Í Á÷Àå¿¡ Á¤½Å°Ç°­ ½ºÅ©¸®´×À» ÅëÇÕÇϱâ À§ÇÑ ±³À°ºÎ ¹× ±â¾÷°úÀÇ Á¦ÈÞ´Â ½ÃÀå ¼ºÀåÀ» À§ÇÑ À¯¸®ÇÑ ±æÀ» Á¦°øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 18¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 20¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â (2030) 32¾ï 2,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 8.11%

Á¦Ç°: AI¿Í µðÁöÅÐ Çõ½ÅÀÌ Á¶±â ¹ß°ß°ú ¿ø°Ý °ü¸®¿¡ ¹ÌÄ¡´Â ¿µÇâ

AI ±â¹Ý ½ºÅ©¸®´× ÅøÀº Á¤±³ÇÑ ¾Ë°í¸®Áò°ú ¸Ó½Å·¯´×À» Ȱ¿ëÇÏ¿© Á¤½Å °Ç°­ ¹®Á¦¸¦ Æò°¡ÇÏ°í ¿¹ÃøÇÕ´Ï´Ù. AI ±â¹ÝÀÇ ½ºÅ©¸®´× ÅøÀº ¹ßÈ­ ÆÐÅÏ, Ç¥Á¤, ÁÖ¸ñÇÒ¸¸ÇÑ Æò°¡¿¡ ´ëÇÑ ¹ÝÀÀ µî ´Ù¾çÇÑ ÃâóÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ ó¸®ÇÏ¿© ÀáÀçÀûÀÎ Á¤½Å °Ç°­ »óŸ¦ Á¶±â¿¡ ½Äº°ÇÕ´Ï´Ù. ¿þ¾î·¯ºí µð¹ÙÀ̽ºÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀº ½É¹Úµ¿ º¯µ¿, ¼ö¸é ÆÐÅÏ, Ȱµ¿ ¼öÁØ µîÀÇ »ý¸®Àû ÆÄ¶ó¹ÌÅ͸¦ ÃßÀûÇϰí Âø¿ëÀÚÀÇ Á¤½Å °Ç°­¿¡ ´ëÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. ¿ø°Ý Á¤½Å °Ç°­ Ç÷§ÆûÀº È­»ó ÅëÈ­, Ä¡·á»ç¿ÍÀÇ ¸Þ½Ã¡, ¿Â¶óÀÎ Áö¿ø ±×·ì µîÀÇ µðÁöÅРä³ÎÀ» ÅëÇØ Á¤½Å °Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. ¸ð¹ÙÀÏ °Ç°­(mHealth) ¾ÛÀº ¿ì¿ïÁõÀ̳ª ºÒ¾ÈÁõ°ú °°Àº Á¤½Å ÁúȯÀÇ Áõ»óÀ» ½ºÅ©¸®´×Çϵµ·Ï ¼³°èµÈ ¼³¹®Áö¸¦ Æ÷ÇÔÇÏ¿© »ç¿ëÀÚ°¡ ÀÚ½ÅÀÇ Á¤½Å °Ç°­À» ÀÚü Æò°¡ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÅÚ·¹Çコ ¼Ö·ç¼ÇÀº Á¤½Å°Ç°­¿¡ ƯȭµÈ Ç÷§Æû¿¡ ±×Ä¡Áö ¾Ê°í Á¤½Å°ú ÀǷḦ Æ÷ÇÔÇÑ º¸´Ù ±¤¹üÀ§ÇÑ °¡»ó ÇコÄÉ¾î ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÅÚ·¹Çコ Ç÷§ÆûÀº ȯÀÚ¿Í ÇコÄɾî Á¦°ø¾÷ü °£ÀÇ È­»óȸÀÇ, ÀüÀÚ Ã³¹æ, Á¤½Å°Ç°­ »óÅÂÀÇ ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚ: Á¤½Å°Ç°­ ½ºÅ©¸®´×À» ¿µ¿ªÀ» °¡·ÎÁú·¯ ÅëÇÕÇÏ°í °³ÀÎÀÇ Á¢±Ù¼º°ú ÀÍ¸í¼º Çâ»ó

ÀÓ»ó ÇöÀå¿¡¼­´Â Á¤½Å °Ç°­ »óÅÂÀÇ Áø´Ü, ¸ð´ÏÅ͸µ ¹× °ü¸®¿¡ »ç¿ëµÇ´Â °íÁ¤¹Ðµµ, ³ôÀº ½Å·Ú¼º, Ç¥ÁØÈ­µÈ Á¤½Å °Ç°­ °Ë»ç µµ±¸°¡ ÇÊ¿äÇÕ´Ï´Ù. ±³À°±â°üÀº ¹ß´Þ ´Ü°è¿¡ ÀûÇÕÇϰí Á¶±â °³ÀÔÀ» ÃËÁøÇÏ¸ç ±³À° ¼º°ú¸¦ Áö¿øÇÏ´Â ½ºÅ©¸®´× µµ±¸¸¦ °­Á¶ÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§ÆûÀº Á¤½Å °Ç°­ Æò°¡¸¦ ¿ä±¸ÇÏ´Â °³ÀÎÀÇ Á¢±Ù¼º°ú ÀÍ¸í¼ºÀ» ³ôÀÌ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù. ±â¾÷¿ë ÇÁ·Î±×·¥Àº È¿À²ÀûÀÌ°í ±â¹Ð¼º ÀÖ´Â ½ºÅ©¸®´×¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç Á÷¿øÀÇ À£´Ï½º ÇÁ·Î±×·¥¿¡ ÅëÇÕÇÔÀ¸·Î½á »ý»ê¼º Çâ»ó°ú °á±Ù·ü ÀúÇϸ¦ µµ¸ðÇÒ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

¾Æ¸Þ¸®Ä« Áö¿ª¿¡¼­´Â Á¤½Å°Ç°­¿¡ ´ëÇÑ ÀǽÄÀÌ ÇöÀúÇÏ°Ô ³ô¾ÆÁö°í ÀÖÀ¸¸ç, °ß°íÇÑ ÇコÄɾî ÀÎÇÁ¶ó°¡ Á¤½Å°Ç°­ ½ºÅ©¸®´× ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. Á¤½Å°Ç°­ °ü·Ã ½ÅÈï±â¾÷°ú ¿¬±¸¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ, Çõ½ÅÀûÀÎ ½ºÅ©¸®´× ±â¼ú ¹× ¿ø°ÝÁ¤½ÅÀÇ·á¿¡ ´ëÇÑ ¾öû³­ ÀÚ±ÝÅõÀÔÀÌ ¾Æ¸Þ¸®Ä« Áö¿ª ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. À¯·´¿¬ÇÕ(EU)Àº Á¤½Å°Ç°­¿¡ ³ôÀº ¿ì¼±¼øÀ§¸¦ µÎ°í ÀÖÀ¸¸ç, °¢±¹Àº ½ºÅ©¸®´×°ú Ä¡·á¿¡ ´Ù¾çÇÑ Á¢±Ù¹ýÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù Á¶»ç¿Í ÀÌ´Ï¼ÅÆ¼ºê´Â ±¹°æÀ» ³Ñ¾î °Ç°­ °ü¸® Çù·Â°ú À¯·´ ȸ¿ø±¹ °£ Á¤½Å °Ç°­ Á¤Ã¥ÀÇ Á¶È­¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«Àº Á¤½ÅÀû ¹®Á¦¿¡ ´ëÇÑ ÀǽÄÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤½Å°Ç°­ ½ºÅ©¸®´×ÀÇ ´Ù¾çÇÑ µµÀü°ú ±âȸ¸¦ Á¦½ÃÇÕ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â Áß±¹, Àεµ, ÀϺ»ÀÌ Á¤½Å °Ç°­¿¡ ´ëÇÑ ÀÇ½Ä Çâ»ó¿¡ ´ëÇÑ ³ë·Â, µðÁöÅÐ ½ºÅ©¸®´× µµ±¸, Á¤½Å °Ç°­ ¿¬±¸ ¹× ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¸¦ ¸ñÇ¥·ÎÇϰí ÀÖ½À´Ï´Ù. ÀÚü ½ºÅ©¸®´×À» À§ÇÑ AI ¹× ¸ð¹ÙÀÏ ¾Û°ú °°Àº Çõ½ÅÀûÀÎ ±â¼úÀÌ °³¹ßµÇ¾úÀ¸¸ç ¾Æ½Ã¾ÆÅÂÆò¾ç Á¤½Å °Ç°­ ±â¼ú ½ÃÀåÀÇ ¼ºÀåÀ» ¹Ý¿µÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå Æò°¡¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ºñÁî´Ï½º Àü·« ¹× Á¦Ç° ¸¸Á·µµ¿Í °ü·ÃµÈ ÁÖ¿ä ÁöÇ¥¸¦ Á¶»çÇÏ°í °ø±Þ¾÷üÀÇ Á¾ÇÕÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¸é¹ÐÇÑ ºÐ¼®À» ÅëÇØ »ç¿ëÀÚ´Â ÀÚ½ÅÀÇ ¿ä±¸ »çÇ׿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. Æò°¡¿¡ µû¶ó °ø±Þ¾÷ü´Â ¼º°øÀÇ Á¤µµ°¡ ´Ù¸¥ 4°³ÀÇ »çºÐ¸éÀ¸·Î ºÐ·ùµË´Ï´Ù: Àü¸é(F), ÆÐ½º ÆÄÀδõ(P), Æ´»õ(N), »ý¸í(V).

½ÃÀå Á¡À¯À² ºÐ¼®

½ÃÀå Á¡À¯À² ºÐ¼®Àº Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ÇöÀç »óÅ¿¡ ´ëÇÑ ÀλçÀÌÆ®ÀÌ ÀÖ´Â »ó¼¼ÇÑ Á¶»ç¸¦ Á¦°øÇÏ´Â Á¾ÇÕÀûÀÎ µµ±¸ÀÔ´Ï´Ù. Àü¹ÝÀûÀÎ ¼öÀÍ, °í°´ ±â¹Ý ¹× ±âŸ ÁÖ¿ä ÁöÇ¥¿¡ ´ëÇÑ °ø±Þ¾÷üÀÇ ±â¿©µµ¸¦ ¸é¹ÐÈ÷ ºñ±³ ¹× ºÐ¼®ÇÔÀ¸·Î½á ±â¾÷ÀÇ ¼º°ú¿Í ½ÃÀå Á¡À¯À² °æÀï¿¡ Á÷¸éÇÏ´Â °úÁ¦¿¡ ´ëÇÑ ÀÌÇØ¸¦ ±í°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ºÐ¼®Àº Á¶»ç ´ë»ó ±âÁس⿡ °üÂûµÈ ´©Àû, ´ÜÆíÈ­ÀÇ ¿ìÀ§, ÇÕº´ÀÇ Æ¯Â¡ µîÀÇ ¿äÀÎÀ» Æ÷ÇÔÇÑ ÀÌ ºÐ¾ßÀÇ °æÀï Æ¯¼º¿¡ ´ëÇÑ ±ÍÁßÇÑ °íÂûÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼¼ºÎ ¼öÁØÀÇ È®´ë¸¦ ÅëÇØ °ø±Þ¾÷ü´Â ´õ ¸¹Àº Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®°í ½ÃÀå¿¡¼­ °æÀï ¿ìÀ§¸¦ Â÷ÁöÇÏ´Â È¿°úÀûÀÎ Àü·«À» °í¾ÈÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ´ÙÀ½ Ãø¸é¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÁÖ¿ä ±â¾÷ÀÌ Á¦°øÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¤º¸¸¦ Á¦½ÃÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´: À¯¸®ÇÑ ½ÅÈï ½ÃÀåÀ» ±íÀÌ ÆÄ°íµé°í ¼º¼÷ÇÑ ½ÃÀå ºÎ¹®ÀÇ Ä§Åõµµ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ½ÅÁ¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ÃÖ±Ù °³¹ß, ÅõÀÚ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : ½ÃÀå Á¡À¯À², Àü·«, Á¦Ç°, ÀÎÁõ, ±ÔÁ¦ »óȲ, ƯÇã »óȲ, ÁÖ¿ä ±â¾÷ÀÇ Á¦Á¶ ´É·Â µîÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ±â¼ú, R&D Ȱµ¿, ȹ±âÀûÀÎ Á¦Ç° °³¹ß¿¡ ´ëÇÑ ÁöÀû ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ´ÙÀ½°ú °°Àº ÁÖ¿ä Áú¹®¿¡ ÇØ´çÇÕ´Ï´Ù.

1. Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå ±Ô¸ð¿Í ¿¹ÃøÀº?

2. Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå ¿¹Ãø ±â°£ µ¿¾È ÅõÀÚ¸¦ °í·ÁÇØ¾ß ÇÒ Á¦Ç°, ºÎ¹®, ¿ëµµ ¹× ºÐ¾ß´Â ¹«¾ùÀΰ¡?

3. Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀåÀÇ ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â?

4. Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå¿¡¼­ ÁÖ¿ä °ø±Þ¾÷ü ½ÃÀå Á¡À¯À²Àº?

5. Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå ÁøÀÔ¿¡ ÀûÇÕÇÑ ÇüÅÂ¿Í Àü·«Àû ¼ö´ÜÀº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Á¤½ÅÁúȯ Áõ°¡
      • ½ºÅ©¸®´× ÅøÀÇ ±â¼úÀû Áøº¸
      • Á¤ºÎ ¹× ÇコÄɾî Á¤Ã¥ÀÇ Áö¿ø
    • ¾ïÁ¦¿äÀÎ
      • ½ºÆ¼±×¸¶¿Í »çȸÀû ±Ý±â
    • ±âȸ
      • AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ
      • ½ÅÈï ½ÃÀå ÁøÃâ°ú °ü¹Î ÆÄÆ®³Ê½Ê
    • °úÁ¦
      • ½ºÅ©¸®´× ÅøÀÇ À¯È¿¼ºÀÇ º¯µ¿°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç°: AI¿Í µðÁöÅÐ Çõ½ÅÀÌ Á¶±â ¹ß°ß°ú ¿ø°Ý ÀÇ·á¿¡ ¹ÌÄ¡´Â ¿µÇâ
    • ÃÖÁ¾ »ç¿ëÀÚ : °³ÀÎÀÇ Á¢±Ù¼º°ú ÀÍ¸í¼ºÀ» ³ôÀ̱â À§ÇØ ¿©·¯ µµ¸ÞÀο¡ °ÉÄ£ Á¤½Å °Ç°­ °Ë»ç¸¦ ÅëÇÕ
  • ½ÃÀå Çõ½Å ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¹ë·ùüÀΰú Áß¿ä °æ·Î ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±â¼ú ºÐ¼®
  • ƯÇ㠺м®
  • ¹«¿ª ºÐ¼®
  • ±ÔÁ¦ ƲÀÇ ºÐ¼®

Á¦6Àå Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå : Á¦Ç°º°

  • AI ±â¹Ý ½ºÅ©¸®´× Åø
  • ¿þ¾î·¯ºí µð¹ÙÀ̽ºÀÇ Áö¼ÓÀûÀÎ °¨½Ã
  • ¿ø°Ý Á¤½Å °Ç°­ Ç÷§Æû
  • ¼¿ÇÁ ½ºÅ©¸®´× mHealth ¾Û
  • ¿ø°Ý ÀÇ·á ¹× °¡»ó ÄÉ¾î ¼Ö·ç¼Ç

Á¦7Àå Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå : ¿¬·ÉÃþº°

  • 0-18¼¼
  • 19-60¼¼
  • 60¼¼ ÀÌ»ó

Á¦8Àå Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå : Áúȯ À¯Çüº°

  • ºÒ¾È
  • ¾ç±Ø¼º Àå¾Ö
  • ¿ì¿ï
  • ¼·½Ä Àå¾Ö
  • ±âºÐÀå¾Ö
  • Á¤½ÅÀå¾Ö

Á¦9Àå Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå : ½ºÅ©¸®´× ¹æ¹ýº°

  • ¹ÙÀÌ¿À¸¶Ä¿ °Ë»ç
  • ÀÓ»ó ¸éÁ¢
  • °üÂû¿¡ ±âÃÊÇÑ Æò°¡
  • ÀÚ±â ½Å°í ¼³¹®Á¶»ç¿Í Á¶»ç

Á¦10Àå Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÀÓ»ó ÇöÀå
  • ±³À°±â°ü
  • ¿Â¶óÀÎ Ç÷§Æû
  • Á÷Àå/±â¾÷ ÇÁ·Î±×·¥

Á¦11Àå ¾Æ¸Þ¸®Ä« Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´,Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Á¤½Å°Ç°­ ½ºÅ©¸®´× ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • ¼±±¸ÀûÀÎ ÆÄÆ®³Ê½ÊÀ» ÅëÇØ AI ÅëÇÕÀ» ÅëÇØ Á¤½Å °Ç°­ °ü¸® Çâ»ó
    • Ellipsis Health¿Í AugmedixÀÇ Àü·«Àû Á¦ÈÞ : ÀÓ»ó ÇöÀå¿¡¼­ AI ÁÖµµ Á¤½Å°Ç°­ ½ºÅ©¸®´×ÀÇ ¼±±¸Àû µµÀÔ
    • United We Care, ¹Ì±¹¿¡¼­ »õ·Î¿î À£´Ï½º ÄÚĪ ÇÁ·Î±×·¥À» µµÀÔÇÏ¿© Çൿ °Ç°­ Çõ½ÅÀ» È®´ë
  • Àü·« ºÐ¼®°ú Á¦¾È

Á¦15Àå °æÀï·Â ÀÖ´Â Æ÷Æ®Æú¸®¿À

  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
  • ÁÖ¿ä Á¦Ç° Æ÷Æ®Æú¸®¿À
BJH 24.05.23

[196 Pages Report] The Mental Health Screening Market size was estimated at USD 1.86 billion in 2023 and expected to reach USD 2.01 billion in 2024, at a CAGR 8.11% to reach USD 3.22 billion by 2030.

The mental health screening is used to identify individuals possessing risk of developing mental health disorders, facilitating early intervention and support. Growing mental health awareness and reduced stigma surrounding mental health issues have significantly contributed to the market's expansion, encouraging individuals to seek help and support. Innovation in digital health technologies enabling remote screening, telepsychiatry, and mobile health apps have broadened the market's reach, providing accessible and convenient options for individuals. Government Initiatives and funding aimed at integrating mental health services into primary healthcare settings have facilitated the growth of the mental health screening market. However, confidentiality concerns around data security & privacy regarding handling sensitive mental health information may hinder market growth. Ensuring that screening tools are culturally sensitive and free from bias remains challenging, potentially affecting accuracy and acceptance among diverse populations. Moreover, leveraging AI for personalized and predictive analytics in mental health screening presents significant opportunities for market advancement. Partnerships with educational and corporate sectors to incorporate mental health screenings in schools and workplaces are expected to offer lucrative avenues for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.86 billion
Estimated Year [2024] USD 2.01 billion
Forecast Year [2030] USD 3.22 billion
CAGR (%) 8.11%

Product: : The Impact of AI and Digital Innovations on Early Detection and Remote Care

AI-based screening tools utilize sophisticated algorithms and machine learning to assess and predict mental health issues. AI-based screening tools process vast amounts of data from various sources, including speech patterns, facial expressions, and responses to targeted assessments, to identify potential mental health conditions early on. Continuous monitoring of wearable devices tracks physiological parameters such as heart rate variability, sleep patterns, and activity levels, offering insights into the wearer's mental health. Remote mental health platforms provide access to mental health services through digital channels, including video calls, messaging with therapists, and online support groups. Mobile health (mHealth) apps enable users to conduct self-assessments of their mental health, including questionnaires designed to screen for symptoms of mental illnesses such as depression and anxiety. Telehealth solutions extend beyond mental health-specific platforms to offer a broader range of virtual healthcare services, including psychiatric care. Telehealth platforms facilitate video conferencing between patients and healthcare providers, electronic prescribing, and monitoring of mental health conditions.

End-User: Integrating Mental Health Screenings Across Domains to Increase Accessibility and Anonymity for Individuals

Clinical settings demand highly accurate, reliable, and standardized mental health screening tools used to diagnose, monitor, and manage mental health conditions. Educational institutions focus on screening tools that are suitable for developmental stages, facilitate early intervention, and support educational outcomes. Online platforms aim to increase accessibility and anonymity for individuals seeking mental health evaluations. Corporate programs focus on efficient, confidential screenings, and can be integrated into employee wellness programs to improve productivity and decrease absenteeism.

Regional Insights

Mental health awareness has significantly increased in the Americas region, driving demand for mental health screening due to robust healthcare infrastructure. Ongoing investments in mental health startups and research, with significant funding directed towards innovative screening technologies and telepsychiatry, are driving the market growth in the Americas region. The European Union places a high priority on mental health, with countries adopting various approaches to screening and treatment. Recent research and initiatives focus on cross-border healthcare cooperation and harmonizing mental health policies across member states in the European region. The MEA region presents varied challenges and opportunities in mental health screening due to rising awareness about mental issues. In the APAC region, China, India, and Japan are witnessing increased mental health awareness initiatives, digital screening tools, and investment in mental health research and facilities. Innovative technologies such as AI and mobile apps for self-screening are being developed, reflecting a growing market landscape for mental health technologies in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Mental Health Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Mental Health Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Mental Health Screening Market, highlighting leading vendors and their innovative profiles. These include AbleTo, Inc., Adaptive Testing Technologies, Inc., Aiberry, Alphabet Inc., American Well Corp (Amwell), Apple Inc., Canary Speech, Inc., Clarigent Health, CogniABle, Ellipsis Health Inc., Epic Systems Corporation, FuturesTHRIVE, GAIA AG, Headspace Inc., Kintsugi Mindful Wellness, Inc., Koninklijke Philips N.V., MindMaze Holding SA, Modern Life, Inc., Otsuka Holdings Co., Ltd., Proem Health, Inc., Quartet Health, Inc., Riverside Community Care, Sonde Health, Inc., SonderMind Inc., and Thymia Limited.

Market Segmentation & Coverage

This research report categorizes the Mental Health Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Al-based Screening Tools
    • Continuous Monitoring Wearable Devices
    • Remote Mental Health Platforms
    • Self-screening mHealth Apps
    • Telehealth & Virtual Care Solutions
  • Age Group
    • Age 0-18 Years
    • Age 19-60
    • Age 60 and above
  • Disease Type
    • Anxiety
    • Bipolar Disorders
    • Depression
    • Eating Disorders
    • Mood Disorders
    • Psychotic Disorders
  • Screening Method
    • Biomarker Testing
    • Clinical Interviews
    • Observation-based Assessments
    • Self-reported Questionnaires & Surveys
  • End-User
    • Clinical Settings
    • Educational Institutions
    • Online Platforms
    • Workplace/Corporate Programs
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Mental Health Screening Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Mental Health Screening Market?

3. What are the technology trends and regulatory frameworks in the Mental Health Screening Market?

4. What is the market share of the leading vendors in the Mental Health Screening Market?

5. Which modes and strategic moves are suitable for entering the Mental Health Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Mental Health Disorders
      • 5.1.1.2. Technological Advancements in Screening Tools
      • 5.1.1.3. Government and Healthcare Policy Support
    • 5.1.2. Restraints
      • 5.1.2.1. Stigma and Social Taboos
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of AI and Machine Learning
      • 5.1.3.2. Expansion into Emerging Markets & Public and Private Partnerships
    • 5.1.4. Challenges
      • 5.1.4.1. Variability in Screening Tool Efficacy and Lack of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: : The Impact of AI and Digital Innovations on Early Detection and Remote Care
    • 5.2.2. End-User: Integrating Mental Health Screenings Across Domains to Increase Accessibility and Anonymity for Individuals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Mental Health Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Al-based Screening Tools
  • 6.3. Continuous Monitoring Wearable Devices
  • 6.4. Remote Mental Health Platforms
  • 6.5. Self-screening mHealth Apps
  • 6.6. Telehealth & Virtual Care Solutions

7. Mental Health Screening Market, by Age Group

  • 7.1. Introduction
  • 7.2. Age 0-18 Years
  • 7.3. Age 19-60
  • 7.4. Age 60 and above

8. Mental Health Screening Market, by Disease Type

  • 8.1. Introduction
  • 8.2. Anxiety
  • 8.3. Bipolar Disorders
  • 8.4. Depression
  • 8.5. Eating Disorders
  • 8.6. Mood Disorders
  • 8.7. Psychotic Disorders

9. Mental Health Screening Market, by Screening Method

  • 9.1. Introduction
  • 9.2. Biomarker Testing
  • 9.3. Clinical Interviews
  • 9.4. Observation-based Assessments
  • 9.5. Self-reported Questionnaires & Surveys

10. Mental Health Screening Market, by End-User

  • 10.1. Introduction
  • 10.2. Clinical Settings
  • 10.3. Educational Institutions
  • 10.4. Online Platforms
  • 10.5. Workplace/Corporate Programs

11. Americas Mental Health Screening Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Mental Health Screening Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Mental Health Screening Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Pioneering Partnership Elevates Mental Health Care Through AI Integration
    • 14.3.2. Strategic Alliance between Ellipsis Health and Augmedix: Pioneering AI-Driven Mental Health Screening in Clinical Settings
    • 14.3.3. United We Care Expands Behavioral Health Innovation with New Wellness Coaching Program in the US
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦